{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:03:10Z","timestamp":1791406990061,"version":"4.3.3"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T00:00:00Z","timestamp":1689724800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Preventive Cardiology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.ajpc.2023.100527","type":"journal-article","created":{"date-parts":[[2023,7,30]],"date-time":"2023-07-30T09:57:13Z","timestamp":1690711033000},"page":"100527","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["The AHA\/ACC\/HFSA 2022 Heart Failure Guidelines: Changing the Focus to Heart Failure Prevention"],"prefix":"10.1016","volume":"15","author":[{"given":"Arielle","family":"Abovich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7010-6298","authenticated-orcid":false,"given":"Daniel S.","family":"Matasic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhanderson","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiadi E.","family":"Ndumele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger S.","family":"Blumenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron","family":"Blankstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0735-9756","authenticated-orcid":false,"given":"Martha","family":"Gulati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpc.2023.100527_bib0001","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1161\/CIR.0000000000001052","article-title":"Heart Disease and Stroke Statistics\u20142022 Update: A Report From the American Heart Association","volume":"145","author":"Tsao","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2023.100527_bib0002","first-page":"678","article-title":"Temporal Trends in the Incidence of and Mortality Associated With Heart Failure With Preserved and Reduced Ejection Fraction","volume":"6","author":"Tsao","year":"2018","journal-title":"JACC: Heart Failure"},{"key":"10.1016\/j.ajpc.2023.100527_bib0003","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1016\/j.amjcard.2019.03.015","article-title":"Relation Between Cigarette Smoking and Heart Failure (from the Multiethnic Study of Atherosclerosis)","volume":"123","author":"Watson","year":"2019","journal-title":"The American Journal of Cardiology"},{"key":"10.1016\/j.ajpc.2023.100527_bib0004","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.021583","article-title":"Heart Failure Risk Associated With Severity of Modifiable Heart Failure Risk Factors: The ARIC Study","volume":"11","author":"Hamo","year":"2022","journal-title":"Journal of the American Heart Association"},{"key":"10.1016\/j.ajpc.2023.100527_bib0005","unstructured":"CDC WONDER. Multiple Cause of Death, 1999-2020 Request Form Accessed June 5, 2022. https:\/\/wonder.cdc.gov\/controller\/datarequest\/D77."},{"key":"10.1016\/j.ajpc.2023.100527_bib0006","article-title":"Understanding the Complexity of Heart Failure Risk and Treatment in Black Patients","volume":"13","author":"Nayak","year":"2020","journal-title":"Circulation: Heart Failure"},{"key":"10.1016\/j.ajpc.2023.100527_bib0007","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cardfail.2021.01.022","volume":"27","author":"Bozkurt","year":"2021","journal-title":"Journal of Cardiac Failure"},{"key":"10.1016\/j.ajpc.2023.100527_bib0008","first-page":"606","article-title":"Forecasting the Impact of Heart Failure in the United States","volume":"6","author":"Heidenreich","year":"2013","journal-title":"Circulation: Heart Failure"},{"key":"10.1016\/j.ajpc.2023.100527_bib0009","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/ejhf.643","article-title":"Echocardiographic screening for non-ischaemic stage B heart failure in the community","volume":"18","author":"Yang","year":"2016","journal-title":"European Journal of Heart Failure"},{"key":"10.1016\/j.ajpc.2023.100527_bib0010","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1016\/j.jacc.2019.02.057","article-title":"10-Year Risk Equations for Incident Heart Failure in the General Population","volume":"73","author":"Khan","year":"2019","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.ajpc.2023.100527_bib0011","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","volume":"71","author":"Whelton","year":"2018","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.ajpc.2023.100527_bib0012","article-title":"Effect of Intensive Blood Pressure Treatment on Heart Failure Events in the Systolic Blood Pressure Reduction Intervention Trial","author":"Upadhya","year":"2017","journal-title":"Circulation: Heart Failure"},{"key":"10.1016\/j.ajpc.2023.100527_bib0013","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/HJH.0000000000000848","article-title":"Effects of blood pressure-lowering treatment. 6. Prevention of heart failure and new-onset heart failure\u2013meta-analyses of randomized trials","volume":"34","author":"Thomopoulos","year":"2016","journal-title":"J Hypertens"},{"key":"10.1016\/j.ajpc.2023.100527_bib0014","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1161\/CIRCULATIONAHA.118.034986","article-title":"Incidence of Hospitalization for Heart Failure and Case-Fatality Among 3.25 Million People With and Without Diabetes Mellitus","volume":"138","author":"McAllister","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2023.100527_bib0015","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1161\/CIRCULATIONAHA.114.014796","article-title":"Impact of Diabetes Mellitus on Hospitalization for Heart Failure, Cardiovascular Events, and Death","volume":"132","author":"Cavender","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2023.100527_bib0016","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12933-020-01011-w","article-title":"Long-term LVEF trajectories in patients with type 2 diabetes and heart failure: diabetic cardiomyopathy may underlie functional decline","volume":"19","author":"Juli\u00e1n","year":"2020","journal-title":"Cardiovascular Diabetology"},{"key":"10.1016\/j.ajpc.2023.100527_bib0017","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.2337\/dc23-S006","article-title":"6. Glycemic Targets: Standards of Care in Diabetes\u20142023","volume":"46","author":"ElSayed","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ajpc.2023.100527_bib0018","doi-asserted-by":"crossref","first-page":"S158","DOI":"10.2337\/dc23-S010","article-title":"10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes\u20142023","volume":"46","author":"ElSayed","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ajpc.2023.100527_bib0019","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.ajpc.2023.100527_bib0020","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2023.100527_bib0021","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Cardiovascular Outcomes, and Mortality in Type 2 Diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.ajpc.2023.100527_bib0022","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(18)32590-X","article-title":"SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials","volume":"393","author":"Zelniker","year":"2019","journal-title":"The Lancet"},{"key":"10.1016\/j.ajpc.2023.100527_bib0023","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1161\/01.CIR.103.22.2668","article-title":"Glycemic control and heart failure among adult patients with diabetes","volume":"103","author":"Iribarren","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2023.100527_bib0024","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/j.jacc.2019.03.010","article-title":"2019 ACC\/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"74","author":"Arnett","year":"2019","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.ajpc.2023.100527_bib0025","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1161\/CIR.0000000000001078","article-title":"Life's Essential 8: Updating and Enhancing the American Heart Association's Construct of Cardiovascular Health: A Presidential Advisory From the American Heart Association","volume":"146","author":"Lloyd-Jones","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2023.100527_bib0026","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.amjmed.2015.03.027","article-title":"American Heart Association's Life's Simple 7: Avoiding Heart Failure and Preserving Cardiac Structure and Function","volume":"128","author":"Folsom","year":"2015","journal-title":"Am J Med"},{"key":"10.1016\/j.ajpc.2023.100527_bib0027","first-page":"520","article-title":"Contribution of Major Lifestyle Risk Factors for Incident Heart Failure in Older Adults: The Cardiovascular Health Study","volume":"3","author":"Del Gobbo","year":"2015","journal-title":"JACC: Heart Failure"},{"key":"10.1016\/j.ajpc.2023.100527_bib0028","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1161\/CIRCHEARTFAILURE.111.962589","article-title":"Lifestyle factors in relation to heart failure among Finnish men and women","volume":"4","author":"Wang","year":"2011","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.ajpc.2023.100527_bib0029","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1161\/CIRCHEARTFAILURE.113.000529","article-title":"Effects of physical activity and sedentary time on the risk of heart failure","volume":"7","author":"Young","year":"2014","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.ajpc.2023.100527_bib0030","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.ehj.2004.10.020","article-title":"Joint effects of physical activity, body mass index, waist circumference and waist-to-hip ratio with the risk of cardiovascular disease among middle-aged Finnish men and women","volume":"25","author":"Hu","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ajpc.2023.100527_bib0031","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1161\/CIRCULATIONAHA.115.015853","article-title":"Dose\u2013Response Relationship Between Physical Activity and Risk of Heart Failure","volume":"132","author":"Pandey","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2023.100527_bib0032","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1007\/s00125-018-4642-y","article-title":"Reduced risk of heart failure with intensified multifactorial intervention in individuals with type 2 diabetes and microalbuminuria: 21 years of follow-up in the randomised Steno-2 study","volume":"61","author":"Oellgaard","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.ajpc.2023.100527_bib0033","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1161\/CIRCULATIONAHA.116.025629","article-title":"Weight Loss and Heart Failure","volume":"135","author":"Sundstr\u00f6m","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2023.100527_bib0034","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S2213-8587(16)30162-0","article-title":"Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial","volume":"4","author":"Group","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.ajpc.2023.100527_bib0035","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/ejhf.481","article-title":"Adherence to a Mediterranean diet is associated with reduced risk of heart failure in men","volume":"18","author":"Tektonidis","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ajpc.2023.100527_bib0036","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/archinternmed.2009.56","article-title":"Consistency With the DASH Diet and Incidence of Heart Failure","volume":"169","author":"Levitan","year":"2009","journal-title":"Archives of Internal Medicine"},{"key":"10.1016\/j.ajpc.2023.100527_bib0037","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.amjcard.2009.06.061","article-title":"Relation of Consistency with the Dietary Approaches to Stop Hypertension Diet and Incidence of Heart Failure in Men Aged 45 to 79 Years","volume":"104","author":"Levitan","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ajpc.2023.100527_bib0038","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1016\/j.jacc.2019.01.067","article-title":"Dietary Patterns and Incident Heart Failure in U.S. Adults Without Known Coronary Disease","volume":"73","author":"Lara","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2023.100527_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.obpill.2023.100069","article-title":"Obesity management for cardiovascular disease prevention","volume":"7","author":"Hritani","year":"2023","journal-title":"Obesity Pillars"},{"key":"10.1016\/j.ajpc.2023.100527_bib0040","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0140-6736(21)00536-5","article-title":"SGLT2 inhibitors and GLP-1 receptor agonists: established and emerging indications","volume":"398","author":"Brown","year":"2021","journal-title":"The Lancet"},{"key":"10.1016\/j.ajpc.2023.100527_bib0041","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1001\/jama.2009.454","article-title":"Efficacy and Safety of Exercise Training in Patients With Chronic Heart Failure: HF-ACTION Randomized Controlled Trial","volume":"301","author":"O'Connor","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.ajpc.2023.100527_bib0042","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jacc.2005.08.050","article-title":"B-Type Natriuretic Peptide Levels in Obese Patients With Advanced Heart Failure","volume":"47","author":"Horwich","year":"2006","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.ajpc.2023.100527_bib0043","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/j.jacc.2003.10.066","article-title":"Obesity and suppressed B-type natriuretic peptide levels in heart failure","volume":"43","author":"Mehra","year":"2004","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.ajpc.2023.100527_bib0044","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure","volume":"79","author":"Heidenreich","year":"2022","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.ajpc.2023.100527_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchf.2022.12.005","article-title":"Reclassification of Pre-Heart Failure Stages Using Cardiac Biomarkers: Atherosclerosis Risk in Communities (ARIC) Study","author":"Jia","year":"2023","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.ajpc.2023.100527_bib0046","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1001\/archinte.159.11.1197","article-title":"Profile for Estimating Risk of Heart Failure","volume":"159","author":"Kannel","year":"1999","journal-title":"Archives of Internal Medicine"},{"key":"10.1016\/j.ajpc.2023.100527_bib0047","first-page":"125","article-title":"Incident Heart Failure Prediction in the Elderly","volume":"1","author":"Butler","year":"2008","journal-title":"Circulation: Heart Failure"},{"key":"10.1016\/j.ajpc.2023.100527_bib0048","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1161\/CIRCHEARTFAILURE.111.964841","article-title":"Prediction of Incident Heart Failure in General Practice: The ARIC Study","volume":"5","author":"Agarwal","year":"2012","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.ajpc.2023.100527_bib0049","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1001\/jamacardio.2022.2496","article-title":"Alerting Clinicians to 1-Year Mortality Risk in Patients Hospitalized With Heart Failure: The REVEAL-HF Randomized Clinical Trial","volume":"7","author":"Ahmad","year":"2022","journal-title":"JAMA Cardiology"},{"key":"10.1016\/j.ajpc.2023.100527_bib0050","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1016\/j.jacc.2021.06.058","article-title":"Race and Ethnicity in Heart Failure: JACC Focus Seminar 8\/9","volume":"78","author":"Pi\u00f1a","year":"2021","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.ajpc.2023.100527_bib0051","article-title":"National Differences in Trends for Heart Failure Hospitalizations by Sex and Race\/Ethnicity","volume":"10","author":"Ziaeian","year":"2017","journal-title":"Circulation: Cardiovascular Quality and Outcomes"},{"key":"10.1016\/j.ajpc.2023.100527_bib0052","article-title":"Risk Factors for Heart Failure","volume":"13","author":"Lawson","year":"2020","journal-title":"Circulation: Heart Failure"},{"key":"10.1016\/j.ajpc.2023.100527_bib0053","article-title":"Social Determinants of Health, and Length of Stay Among Hospitalized Patients With Heart Failure: An Analysis From the Get With The Guidelines-Heart Failure Registry","volume":"15","author":"Segar","year":"2022","journal-title":"Circulation: Heart Failure"},{"key":"10.1016\/j.ajpc.2023.100527_bib0054","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1001\/archinte.168.19.2138","article-title":"Differences in the Incidence of Congestive Heart Failure by Ethnicity: The Multi-Ethnic Study of Atherosclerosis","volume":"168","author":"Bahrami","year":"2008","journal-title":"Archives of Internal Medicine"},{"key":"10.1016\/j.ajpc.2023.100527_bib0055","doi-asserted-by":"crossref","unstructured":"Daviglus M.L., Pirzada A., Durazo-Arvizu R., et\u00a0al. Prevalence of Low Cardiovascular Risk Profile Among Diverse Hispanic\/Latino Adults in the United States by Age, Sex, and Level of Acculturation: The Hispanic Community Health Study\/Study of Latinos. Journal of the American Heart Association. 5:e003929.","DOI":"10.1161\/JAHA.116.003929"},{"key":"10.1016\/j.ajpc.2023.100527_bib0056","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1001\/jama.2012.14517","article-title":"Prevalence of Major Cardiovascular Risk Factors and Cardiovascular Diseases Among Hispanic\/Latino Individuals of Diverse Backgrounds in the United States","volume":"308","author":"Daviglus","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.ajpc.2023.100527_bib0057","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1016\/j.jacc.2014.08.048","article-title":"Cardiovascular Disease Mortality in Asian Americans","volume":"64","author":"Jose","year":"2014","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.ajpc.2023.100527_bib0058","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jacc.2022.04.042","article-title":"Cardiovascular Disease Risk Among Cancer Survivors: The Atherosclerosis Risk In Communities (ARIC) Study","volume":"80","author":"Florido","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2023.100527_bib0059","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","volume":"43","author":"Lyon","year":"2022","journal-title":"European Heart Journal"},{"key":"10.1016\/j.ajpc.2023.100527_bib0060","article-title":"Race, Racism, and Cardiovascular Health: Applying a Social Determinants of Health Framework to Racial\/Ethnic Disparities in Cardiovascular Disease","volume":"15","author":"Javed","year":"2022","journal-title":"Circulation: Cardiovascular Quality and Outcomes"},{"key":"10.1016\/j.ajpc.2023.100527_bib0061","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM199209033271001","article-title":"Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction","volume":"327","author":"Pfeffer","year":"1992","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.ajpc.2023.100527_bib0062","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1056\/NEJM199512213332503","article-title":"A Clinical Trial of the Angiotensin-Converting\u2013Enzyme Inhibitor Trandolapril in Patients with Left Ventricular Dysfunction after Myocardial Infarction","volume":"333","author":"K\u00f8ber","year":"1995","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.ajpc.2023.100527_bib0063","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJM199209033271003","article-title":"Effect of Enalapril on Mortality and the Development of Heart Failure in Asymptomatic Patients with Reduced Left Ventricular Ejection Fractions","volume":"327","author":"Yusuf","year":"1992","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.ajpc.2023.100527_bib0064","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/S0140-6736(03)13501-5","article-title":"Effect of enalapril on 12-year survival and life expectancy in patients with left ventricular systolic dysfunction: a follow-up study","volume":"361","author":"Jong","year":"2003","journal-title":"The Lancet"},{"key":"10.1016\/j.ajpc.2023.100527_bib0065","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1056\/NEJMoa032292","article-title":"Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both","volume":"349","author":"Pfeffer","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2023.100527_bib0066","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1388-9842(03)00112-0","article-title":"VALsartan In Acute myocardial iNfarcTion (VALIANT) trial: baseline characteristics in context","volume":"5","author":"Velazquez","year":"2003","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ajpc.2023.100527_bib0067","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1016\/j.jacc.2006.03.034","article-title":"Intensive statin therapy and the risk of hospitalization for heart failure after an acute coronary syndrome in the PROVE IT-TIMI 22 study","volume":"47","author":"Scirica","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2023.100527_bib0068","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1136\/hrt.2006.112508","article-title":"Intensive statin therapy in acute coronary syndromes and stable coronary heart disease: a comparative meta-analysis of randomised controlled trials","volume":"93","author":"Afilalo","year":"2007","journal-title":"Heart"},{"key":"10.1016\/j.ajpc.2023.100527_bib0069","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1071-9164(97)90022-1","article-title":"The effects of simvastatin on the incidence of heart failure in patients with coronary heart disease","volume":"3","author":"Kjekshus","year":"1997","journal-title":"J Card Fail"},{"key":"10.1016\/j.ajpc.2023.100527_bib0070","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1093\/eurheartj\/ehv072","article-title":"The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trials","volume":"36","author":"Preiss","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ajpc.2023.100527_bib0071","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0140-6736(00)04560-8","article-title":"Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial","volume":"357","author":"Dargie","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ajpc.2023.100527_bib0072","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S0735-1097(98)00675-5","article-title":"Beta-adrenergic blocking agent use and mortality in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a post hoc analysis of the studies of left ventricular dysfunction","volume":"33","author":"Exner","year":"1999","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.ajpc.2023.100527_bib0073","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0735-1097(96)00489-5","volume":"29","author":"Vantrimpont","year":"1997","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.ajpc.2023.100527_bib0074","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.2337\/dc07-0717","article-title":"Pioglitazone Use and Heart Failure in Patients With Type 2 Diabetes and Preexisting Cardiovascular Disease: Data from the PROactive Study (PROactive 08)","volume":"30","author":"Erdmann","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ajpc.2023.100527_bib0075","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1093\/eurheartj\/ehp604","article-title":"Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trial","volume":"31","author":"Komajda","year":"2010","journal-title":"European Heart Journal"},{"key":"10.1016\/j.ajpc.2023.100527_bib0076","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/j.jacc.2006.10.077","article-title":"A Randomized, Placebo-Controlled Trial Assessing the Effects of Rosiglitazone on Echocardiographic Function and Cardiac Status in Type 2 Diabetic Patients With New York Heart Association Functional Class I or II Heart Failure","volume":"49","author":"Dargie","year":"2007","journal-title":"Journal of the American College of Cardiology"}],"container-title":["American Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666667723000685?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666667723000685?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:38:15Z","timestamp":1763005095000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666667723000685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":76,"alternative-id":["S2666667723000685"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpc.2023.100527","relation":{},"ISSN":["2666-6677"],"issn-type":[{"value":"2666-6677","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The AHA\/ACC\/HFSA 2022 Heart Failure Guidelines: Changing the Focus to Heart Failure Prevention","name":"articletitle","label":"Article Title"},{"value":"American Journal of Preventive Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpc.2023.100527","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100527"}}